Finn RS - Search Results

1

AASLD guidelines for the treatment of hepatocellular carcinoma.

Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, Zhu AX, Murad MH, Marrero JA. Heimbach JK, et al. Among authors: finn rs. Hepatology. 2018 Jan;67(1):358-380. doi: 10.1002/hep.29086. Hepatology. 2018. PMID: 28130846 No abstract available.

2

Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation.

Lu DS, Yu NC, Raman SS, Lassman C, Tong MJ, Britten C, Durazo F, Saab S, Han S, Finn R, Hiatt JR, Busuttil RW. Lu DS, et al. Hepatology. 2005 May;41(5):1130-7. doi: 10.1002/hep.20688. Hepatology. 2005. PMID: 15841454

3

Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab.

Finn RS, Zhu AX. Finn RS, et al. Expert Rev Anticancer Ther. 2009 Apr;9(4):503-9. doi: 10.1586/era.09.6. Expert Rev Anticancer Ther. 2009. PMID: 19374603 Review.

4

Development of molecularly targeted therapies in hepatocellular carcinoma: where do we go now?

Finn RS. Finn RS. Clin Cancer Res. 2010 Jan 15;16(2):390-7. doi: 10.1158/1078-0432.CCR-09-2084. Epub 2010 Jan 12. Clin Cancer Res. 2010. PMID: 20068087 Review.

5

Drug therapy: sorafenib.

Finn RS. Finn RS. Hepatology. 2010 May;51(5):1843-9. doi: 10.1002/hep.23676. Hepatology. 2010. PMID: 20432260 No abstract available.

6

Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.

Clavien PA, Lesurtel M, Bossuyt PM, Gores GJ, Langer B, Perrier A; OLT for HCC Consensus Group. Clavien PA, et al. Lancet Oncol. 2012 Jan;13(1):e11-22. doi: 10.1016/S1470-2045(11)70175-9. Epub 2011 Oct 31. Lancet Oncol. 2012. PMID: 22047762 Free PMC article.

7

Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.

Finn RS, Kang YK, Mulcahy M, Polite BN, Lim HY, Walters I, Baudelet C, Manekas D, Park JW. Finn RS, et al. Clin Cancer Res. 2012 Apr 1;18(7):2090-8. doi: 10.1158/1078-0432.CCR-11-1991. Epub 2012 Jan 11. Clin Cancer Res. 2012. PMID: 22238246 Clinical Trial.

8

Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: a pilot study.

Britten CD, Gomes AS, Wainberg ZA, Elashoff D, Amado R, Xin Y, Busuttil RW, Slamon DJ, Finn RS. Britten CD, et al. Among authors: finn rs. BMC Cancer. 2012 Jan 14;12:16. doi: 10.1186/1471-2407-12-16. BMC Cancer. 2012. PMID: 22244160 Free PMC article. Clinical Trial.

9

Molecular subtype and response to dasatinib, an Src/Abl small molecule kinase inhibitor, in hepatocellular carcinoma cell lines in vitro.

Finn RS, Aleshin A, Dering J, Yang P, Ginther C, Desai A, Zhao D, von Euw E, Busuttil RW, Slamon DJ. Finn RS, et al. Hepatology. 2013 May;57(5):1838-46. doi: 10.1002/hep.26223. Epub 2013 Apr 1. Hepatology. 2013. PMID: 23299860

10

Emerging targeted strategies in advanced hepatocellular carcinoma.

Finn RS. Finn RS. Semin Liver Dis. 2013 Feb;33 Suppl 1:S11-9. doi: 10.1055/s-0033-1333632. Epub 2013 Mar 1. Semin Liver Dis. 2013. PMID: 23457035 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

247 results

Search Page